Inici ›

Publications

Filtres: Autor és Crous-Bou, M  [Clear All Filters]
2012
Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, et al. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis. 2012;27(2):169-76. Abstract
Sanz-Pamplona R, Berenguer A, Sole X, Cordero D, Crous-Bou M, Serra-Musach J, et al. Tools for protein-protein interaction network analysis in cancer research. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2012;14(1):3-14. Abstract
Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, et al. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration. The pharmacogenomics journal. 2012. Abstract
Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, et al. Clinical Value of Prognosis Gene Expression Signatures in Colorectal Cancer: A Systematic Review. PloS one. 2012;7(11):e48877. Abstract
2009
Porta M, Crous-Bou M, Wark PA, Vineis P, Real FX, Malats N, et al. Cigarette smoking and K-ras mutations in pancreas, lung and colorectal adenocarcinomas: etiopathogenic similarities, differences and paradoxes. Mutation research. 2009;682(2-3):83-93. Abstract
Porta M, López T, Pumarega J, Jariod M, Crous-Bou M, Marco E, et al. In pancreatic ductal adenocarcinoma blood concentrations of some organochlorine compounds and coffee intake are independently associated with KRAS mutations. Mutagenesis. 2009;24(6):513-21. Abstract
Crous-Bou M, Porta M, López T, Jariod M, Malats N, Morales E, et al. Lifetime history of alcohol consumption and K-ras mutations in pancreatic ductal adenocarcinoma. Environmental and molecular mutagenesis. 2009;50(5):421-30. Abstract
Crous-Bou M, Porta M, Morales E, López T, Carrato A, Puigdomènech E, et al. Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9. Abstract
2008
Crous-Bou M, De Vivo I, Porta M, Pumarega JA, López T, Alguacil J, et al. CYP1B1 polymorphisms and k-ras mutations in patients with pancreatic ductal adenocarcinoma. Digestive diseases and sciences. 2008;53(5):1417-21. Abstract
Porta M, Ferrer-Armengou O, Pumarega J, López T, Crous-Bou M, Alguacil J, et al. Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. Journal of clinical epidemiology. 2008;61(7):695-704. Abstract
2007
Morales E, Porta M, Vioque J, López T, Mendez MA, Pumarega J, et al. Food and nutrient intakes and K-ras mutations in exocrine pancreatic cancer. Journal of epidemiology and community health. 2007;61(7):641-9. Abstract
Porta M, Hernández-Aguado I, Lumbreras B, Crous-Bou M. "Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? Journal of clinical epidemiology. 2007;60(12):1220-5; discussion 1226-8. Abstract
Crous-Bou M, Porta M, López T, Jariod M, Malats N, Alguacil J, et al. Lifetime history of tobacco consumption and K-ras mutations in exocrine pancreatic cancer. Pancreas. 2007;35(2):135-41. Abstract